Navigation Links
HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer
Date:6/13/2011

MUMBAI, India, June 13, 2011 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its U.S. subsidiary, Lupin Pharmaceutical Inc. was presented with the 2011 DIANA Award by the Healthcare Distribution Management Association (HDMA) for the Best Overall Generic Product Manufacturer among those companies with sales of up to $100 million in the Healthcare Distributor market.

The DIANA award winners are selected by HDMA Distributor members to recognize companies that continually foster strong trading partner relationships with the Association's primary distributor members by creating exceptional business practices that advance trade relations and benefit the entire US healthcare supply chain.  

Commenting on the award, Paul McGarty, President of Lupin Pharmaceuticals Inc. said, "We are very pleased and honored with the recognition that Lupin received from the HDMA."  Mr. McGarty added, "This is very exciting when we consider that Lupin launched its Generics Rx division in December 2005 and this award is a reflection of our unwavering commitment to excellence and collaborative relationships with our trading partners."

About Lupin Limited

Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs. The Company today has significant presence in Cardiovasculars (prils and statins), Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAIDs in addition to holding global leadership positions in the Anti-TB and Cephalosporins space.

Today, Lupin is the 5th largest and the fastest growing Top 5 generics player in the U.S. (by prescriptions), the only Asian company to achieve that distinction. The company is also the fastest growing top 10 pharmaceutical players in India, Japan and South Africa. (IMS)

For the financial year ended March 2011, Lupin's Consolidated Sales and Profit after Tax were Rs. 57,068 million and Rs. 8,626 million respectively. Please visit http://www.lupinworld.com for more information about Lupin Ltd.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Ltd.  Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, affordable generic medicines and branded formulations trusted by healthcare professionals and patients across geographies. For more information, visit http://www.lupinpharmaceuticals.com.

For further information please contact:

Shamsher Gorawara
Lupin Limited:
Ph: +91 98 20 338 555
Email: shamshergorawara@lupinpharma.com

OR

Sonia Mansata
Text 100 Public Relations
Ph: +91 98 20 11 2481
Email: sonia.mansata@text100.co.in

Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995:

This release contains forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Many of these risks, uncertainties and other factors include failure of clinical trials, delays in development, registration and product approvals, changes in the competitive environment, increased government control over pricing, fluctuations in the capital and foreign exchange markets and the ability to maintain patent and other intellectual property protection. The information presented in this release represents management's expectations and intentions as of this date. Lupin expressly disavows any obligation to update the information presented in this release.

(BSE : 500257)

(NSE: Lupin)

(REUTERS: LUPN.BO)

(BLOOMBERG: LPC IN)


'/>"/>
SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AmeriCares Honors AstraZeneca with Power of Partnership Award
2. CIO magazine Honors Life Technologies for Leadership in Information Technology
3. Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executives 2011 Executive 100
4. Elekta-sponsored Ceremony Honors Arizona Cancer Heroes
5. Generic Drug Industry Honors PCMA President & CEO Mark Merritt with Prestigious Outstanding Contribution Award
6. DK Sinopharma, Inc. Reviews its Honors of the Year 2010
7. Charlotte Business Journal Honors Prodigy Diabetes Care, LLC With Fast 50 Award
8. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
9. Regence Foundation Honors Palliative Care Leaders
10. MedShape Solutions, Inc. Receives Industry Honors and Awards
11. Annual Welcome Back Awards Program Honors Individuals for Tremendous Contributions to the Depression Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):